Table 2 Selected oligonucleotide sequence candidates. Twenty-five most frequent oligonucleotide sequences obtained after next-generation sequencing (NGS) of the 8th Cell-Selex cycle. Only the sequence corresponding to the random region is shown. Primer binding sites were neglected in this representation.

From: Selection of aptamers against triple negative breast cancer cells using high throughput sequencing

Aptamer ID

Sequences (5′–3′)

Copies

Apt1

‘GCATCCACCGTGAATATTGTAACGCTATATGTGAGTGGCTAAGTGCACC'

89

Apt2

‘ATGTTGTTGCCGGGACGCCTCCTTCACCAAAGTTGGTGTCCCCACCTAC'

86

Apt3

‘TCGGGTGATGGGTGGACAAAAGTTAGTAGCCGCGAGCCACTGGCCCAGT'

79

Apt4

‘AATGAGTGTCATCCGACTAAGATCTATTTTAAGCTCGACTCGTTTGGCA'

64

Apt5

‘CGCGGTGTTATGAGGGGACAAGTACAAATCAATGTCGCCGCGTAGCCGC'

59

Apt6

‘ATGCAAGTGTTGCCGCGCAAACAATGCCTCCTGCTTATTTGTGCCACCA'

59

Apt7

‘AGGGAGGTAGCGTGCCCACCAGGAGTTTTGCGCTATACGATGTTGCTGG'

58

Apt8

GATGACTGGTCATACGCGCGATAAGTATATGCTGCCACCGGAGTTGCCG'

56

Apt9

‘GACGATGTGGTCCGCTGGAATTTTGCGAGCCCGCTATATGAAATCGCCA'

56

Apt10

‘CGCCAAGGTCCGGAAGCGGAGTTAGTAGCCGCGAAATCACTGGCCCTCA'

49

Apt11

‘ATGCCATACGAAGTTGCCGCGTATTCTTTGCTAACGCCACCGGAGTATG'

49

Apt12

‘CTGACGATCCGGGCCAAGATAATCTCTGCGATCAGTCGCCAGTCTTTCG'

38

Apt13

‘GATTAGTACGCGCATGTTGTCGTTTTTCGGAACCACCAGTAGCGTTCGC'

37

Apt14

‘CGAAGTTTGTAGCCGCGGAACTACTGGCACGTCATTGCGTATCAGGTTG'

36

Apt15

‘TGGCCATCGGTCTTGTTGCCGAGACCCAGCTCTCCACCATTCCGATCGC'

35

Apt16

‘CGAGTCGTGGGATCTCCACAATCCGCCGAATTAGTTGCGCCACACCACA'

34

Apt17

‘TAGAGCCACTGAACCTTACCTGGCCCTGCAGAAGGTGAATTGCCGCGTA'

31

Apt18

‘CGCAGGGTGTAGCCGCGATCCACTGGGTTCTTCCGTTGTACGTTGACGG'

29

Apt19

‘AATTGGACAGTATTAGCCAGTCGCCATGAACTCTTGAGTACCATCGCCG'

29

Apt20

‘GACATTACCCATCTAGACGGGGGTTATTCTTAGTAGCCGCGAAACCGTG'

29

Apt21

‘CGCCGGTATAATTCGAAACATGAGTATTAGTAAGTCGAGGAGCGGCCGC'

28

Apt22

‘GCCGTCCGTTCCCGCAAGGGTATCCACGTTCTTAGTTTGTAGCTGCGAG'

28

Apt23

‘TCCGCATGGTTCAGATATGTTGCCGCCACGAAATGGCCACCAATGACCT'

28

Apt24

‘ACAGACGTGTTTGTAGCCGCGAAACTACTGGCAACTTACCCAAATCTCG'

25

Apt25

‘GAGCAGTCGCCACCGTATCTATTACGAGACTATAGAACGTTGCCGCGAC'

25